Encoded Therapeutics inks $104 mln Series C
South San Francisco-based Encoded Therapeutics Inc, a precision gene therapy company, has secured $104 million in Series C funding. The investors included Venrock, ARCH Venture Partners, Matrix Capital Management, Illumina Ventures and Altitude Life Science Ventures.
26 June 2019•1 min read
